Healthcare focus AplusA specializes in pharmaceutical and life sciences insights, presenting a clear opportunity to position advanced analytics and real-world evidence services to pharma/biotech teams targeting immunology and oncology therapeutic areas.

Global engagement With worldwide partnerships in healthcare, there is potential to expand into multi-region studies, cross-market payer insights, and global health data intelligence offerings for multinational sponsors seeking consistent analytics across markets.

Recent leadership A new CEO appointed in December 2024 signals strategic refresh and growth initiatives; align outreach to senior decision-makers about scalable consultative services, productized studies, and expanded syndicated research offerings.

Venture-ready studies Launched RSV vaccination syndicated study and ISPOR Europe 2025 posters indicate momentum in real-world evidence and vaccine/heath economics topics; propose partnerships for co-branded studies, early access programs, and sponsor-ready data packages.

Tech-enabled insights Utilizes AI analytics, digital listening and Power BI among other tools; pitch advanced analytics, dashboards, and custom ROE dashboards to optimize clinical development, market access, and patient outcomes for life science clients.